Trial Profile

Phase I/II trial of Personalised prostate cancer therapy in in advanced prostate cancer

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 18 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

10 Sep 2024 According to a BriaCell Therapeutics Corp media release, the company plans to initiate the Phase 1/2 study pending completion of standard manufacturing and testing requirements.
10 Sep 2024 According to a BriaCell Therapeutics Corp media release, the company is pleased to announce that it has received positive feedback from its Pre-IND meeting with the U.S. Food and Drug Administration (FDA), which is a step forward to opening an IND to conduct a Phase 1/2 study of Bria-PROS+™, in advanced prostate cancer.
07 Mar 2024 According to a BriaCell Therapeutics Corp media release, company received and executes letter of intent to advance clinical development of Bria-PROS in prostate cancer.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com